Skip to main content

Pfizer agrees to settle more than 10K lawsuits over Zantac cancer risk: Bloomberg News

Packages of Zantac are pictured in this 2019 file photo. (AP Photo/Mark Lennihan) Packages of Zantac are pictured in this 2019 file photo. (AP Photo/Mark Lennihan)
Share

Pfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported on Wednesday, citing people familiar with the deal.

The agreements cover cases in U.S. state courts but don't completely resolve the company's exposure to Zantac claims, the report said, adding that financial details of the deals were not immediately available.

Pfizer did not immediately respond to a Reuters request for comment.

In 2020, the U.S. Food and Drug Administration asked drugmakers to pull Zantac and its generic versions off the market after a cancer-causing substance called NDMA was found in samples of the drug.

Thousands of lawsuits began piling up in federal and state courts against Pfizer, GSK GSK.L, Sanofi SASY.PA and Boehringer Ingelheim.

CTVNews.ca Top Stories

Here are the signs you're ready to downsize your home

Amid the cost-of-living crisis, many Canadians are looking to find ways to save money, such as downsizing their home. But one Ottawa broker says there are several signs to consider before making the big decision.

Local Spotlight

Video shows B.C. grizzly basking in clawfoot tub

A donated clawfoot bathtub has become the preferred lounging spot for a pair of B.C. grizzly bears, who have been taking turns relaxing and reclining in it – with minimal sibling squabbling – for the past year.